Brinks Company (BCO)
Return on equity (ROE)
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income (ttm) | US$ in thousands | 162,900 | 119,400 | 136,100 | 122,000 | 87,700 | 137,700 | 111,300 | 114,300 | 170,600 | 175,200 | 175,000 | 163,800 | 105,200 | 80,800 | 37,900 | 26,900 | 16,000 | -11,800 | 17,500 | 17,100 |
Total stockholders’ equity | US$ in thousands | 312,500 | 277,100 | 320,500 | 396,400 | 397,400 | 462,800 | 664,200 | 605,000 | 570,200 | 202,700 | 240,500 | 240,000 | 252,600 | 249,000 | 174,000 | 225,100 | 202,500 | 90,000 | 111,300 | 82,000 |
ROE | 52.13% | 43.09% | 42.46% | 30.78% | 22.07% | 29.75% | 16.76% | 18.89% | 29.92% | 86.43% | 72.77% | 68.25% | 41.65% | 32.45% | 21.78% | 11.95% | 7.90% | -13.11% | 15.72% | 20.85% |
December 31, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $162,900K ÷ $312,500K
= 52.13%
Brinks Company's return on equity (ROE) has shown fluctuations over the periods analyzed. From March 31, 2020, to December 31, 2024, the ROE varied between -13.11% and 86.43%.
The ROE improved significantly from negative figures in September 2020 to a high of 86.43% in September 2022, indicating a strong performance in generating profits relative to shareholders' equity. This peak was sustained in the following quarter, December 2022, before experiencing a decline to 29.92%.
Following the temporary drop, the ROE recovered moderately in the first quarter of 2023, reaching 18.89%, and continued to increase gradually over the subsequent quarters. By December 31, 2024, the ROE stood at 52.13%.
Overall, the ROE trend indicates that Brinks Company has demonstrated the ability to utilize shareholder equity efficiently to generate profits, with some periods of exceptional performance and others of more modest growth. Continued monitoring of the ROE will be essential to assess the company's ongoing financial health and performance.
Peer comparison
Dec 31, 2024